Ultrasound-orchestrated collapse of cancer stem cell niches through synergistic physical barrier disruption and intracellular homeostasis reprogramming
Source abstract
Abstract
Cancer stem cells (CSCs) are a critical subpopulation within heterogeneous tumors which are largely responsible for therapeutic resistance, recurrence and metastasis. Herein, we report an ultrasound-mediated strategy based on a sono-responsive core-shell nanoplatform (MTCA) that concurrently disrupts physical barriers and reprograms intracellular homeostasis to precisely regulate and eradicate CSCs. The MTCA was engineered and surface-modified with a carbonic anhydrase IX (CAIX) inhibitor to enable selective targeting of CAIX-overexpressing CSCs and perturb their pH homeostasis. The copper-titanium dioxide shell depletes intracellular glutathione and amplifies reactive oxygen species generation under ultrasound activation, thereby overcoming CSC-associated antioxidant defenses. Meanwhile, ultrasound-induced mechanical effect transiently disrupts extracellular integrity, significantly enhancing nanoplatform penetration into CSC-enriched tumor region. This synergistic approach was found to effectively downregulate stemness-associated gene expression and suppresses CSC viability in CSC-enriched 3D tumors spheroids, which also inhibited tumor growth and metastasis in in vivo tumor models. Collectively, this study establishes an ultrasound-enabled paradigm for coordinated physical and biochemical modulation of CSC niches, offering a promising strategy to overcome CSC-driven therapeutic resistance.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Ultrasound and Hyperthermia Applications · Cancer Cells and Metastasis · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Stem cells, cancer, and cancer stem cells10.1038/35102167 ↗
2. Nanotherapeutic strategies exploiting biological traits of cancer stem cells
3. Advances in nanomedicine for targeting cancer stem cells and overcoming therapeutic resistance10.1021/acsnano.5c02321 ↗
4. Cancer stem cell niche: the place to be10.1158/0008-5472.CAN-10-3220 ↗
5. Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment10.1186/s12943-023-01748-4 ↗
6. Matrix stiffening promotes a tumor vasculature phenotype10.1073/pnas.1613855114 ↗
7. Matrix stiffness drives epithelial–mesenchymal transition and tumour metastasis through a TWIST1–G3BP2 mechanotransduction pathway10.1038/ncb3157 ↗
8. Modulating tumor mechanics with nanomedicine for cancer therapy10.1039/D3BM00363A ↗
9. Ultrasound-mediated intra-/extracellular dual intervening effect combined with all-trans retinoic acid for cancer stemness inhibition10.1016/j.nantod.2024.102207 ↗
10. Carbonic anhydrase IX and acid transport in cancer10.1038/s41416-019-0642-z ↗
11. Modulating tumor acidity with hydroxyethyl starch-based nanoparticles by targeting CA9 to eliminate cancer stem cells and overcome immunosuppression10.1016/j.biomaterials.2025.123501 ↗
12. Cancer stem-like cells-oriented surface self-assembly to conquer radioresistance10.1002/adma.202302916 ↗
13. A small molecule strategy for targeting cancer stem cells in hypoxic microenvironments and preventing tumorigenesis10.1021/jacs.1c03875 ↗
14. Association of reactive oxygen species levels and radioresistance in cancer stem cells10.1038/nature07733 ↗
15. Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance10.1016/j.redox.2021.101953 ↗
16. Biomineralization-Tuned nanounits reprogram the signal transducer and activator of transcription 3 signaling for ferroptosis-immunotherapy in cancer stem cells10.1021/acsnano.4c05084 ↗
17. A “Ferroptosis-Amplifier” hydrogel for eliminating refractory cancer stem cells post-lumpectomy10.1021/acs.nanolett.4c02192 ↗
18. Oxidative stress in cancer10.1016/j.ccell.2020.06.001 ↗
19. Targeting ROS in cancer: rationale and strategies10.1038/s41573-024-00979-4 ↗
20. F. Liu, S. Ning, X. Wang, X. Fan, B. Wan, F. Sun, L. Du, K. Shi, X. Zou, R. Zhu, M. Li, W. Shen, Z. He, K. Wang, J. Sun, Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy, Sci. Adv. 11(36) eadr8001.10.1126/sciadv.adr8001 ↗
21. Double-Layered hollow mesoporous cuprous oxide nanoparticles for double drug sequential therapy of tumors10.1002/adma.202313212 ↗
22. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents10.1038/s41392-020-00430-1 ↗
23. Sniping cancer stem cells with nanomaterials10.1021/acsnano.3c07828 ↗
24. Regulation of iron metabolism and ferroptosis in cancer stem cells
25. Extracellular matrix remodeling in vivo for enhancing tumor-targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound10.1016/j.jconrel.2017.02.035 ↗
26. Low-intensity pulsed ultrasound-generated singlet oxygen induces telomere damage leading to glioma stem cell awakening from quiescence10.1016/j.isci.2021.103558 ↗
27. Modeling low-intensity ultrasound mechanotherapy impact on growing cancer stem cells10.1016/j.matcom.2024.08.030 ↗
28. Migration and invasion of cancer stem cells are prevented by low-intensity pulsed ultrasound therapy10.1186/s12935-025-03854-3 ↗
29. Sonodynamic and sonomechanical effect on cellular stemness and extracellular physicochemical environment to potentiate chemotherapy10.1186/s12951-024-02623-0 ↗
30. Ultrasound and microbubbles to beat barriers in tumors: improving delivery of nanomedicine10.1016/j.addr.2021.113847 ↗